Extraesophageal Manifestations of GERD
Recognized Manifestations
Gastroenterologists must actively screen GERD patients for laryngitis, chronic cough, asthma, and dental erosions, as these represent the most well-established extraesophageal manifestations with the strongest evidence base. 1, 2
The spectrum of extraesophageal reflux (EER) manifestations includes:
Primary Manifestations (Strongest Evidence)
- Chronic cough 1, 2
- Laryngitis and laryngeal hoarseness 1, 2
- Dysphonia 1
- Asthma 1, 2
- Dental erosions and caries 1, 2
Additional Recognized Manifestations
- Pulmonary fibrosis 1, 2
- Sinus disease 1, 2
- Ear disease 1, 2
- Post-nasal drip 1, 2
- Throat clearing 1, 2
- Globus sensation 1
Critical Diagnostic Considerations
Up to 75% of patients with extraesophageal manifestations lack typical heartburn or regurgitation, placing the diagnostic burden entirely on the clinician to recognize GERD as a potential contributor. 2
Key Diagnostic Pitfalls to Avoid
- Do not prescribe PPIs empirically for isolated extraesophageal symptoms without laryngoscopy or objective testing - this approach has failed in multiple meta-analyses showing no benefit over placebo 3, 2
- Laryngoscopy is mandatory before initiating antireflux therapy for suspected laryngopharyngeal reflux to confirm laryngeal inflammation and exclude alternative diagnoses 3
- Consider objective pH-metry testing upfront in patients with isolated extraesophageal symptoms, as 50-60% will not have GERD as the underlying cause 2
Multidisciplinary Evaluation Required
A multidisciplinary approach with communication between treating disciplines results in the best outcomes for suspected EER patients. 1
Essential specialist involvement includes:
- Otolaryngology - for laryngeal/ENT symptoms including laryngitis, hoarseness, globus, throat clearing, and sinus inflammation 1
- Pulmonology - for asthma, chronic cough, and pulmonary fibrosis 1
- Dentistry - for dental erosions and caries 1
- Allergy/Immunology - to exclude laryngeal allergy and vocal cord dysfunction 1
- Speech pathology - for functional dysphonia and muscle tension dysphonia 1
- Behavioral psychology - for behavioral components 1
Results from bronchoscopy, thoracic imaging, and laryngoscopy from non-GI disciplines must be incorporated when considering GER as a cause for extraesophageal symptoms 1
Management Algorithm
Step 1: Determine Presence of Typical GERD Symptoms
For patients WITH heartburn/regurgitation plus extraesophageal symptoms:
- Implement lifestyle modifications: weight loss if BMI >25, head of bed elevation, avoiding meals within 2-3 hours of bedtime 3
- Start PPI therapy: omeprazole 40 mg twice daily, esomeprazole 40 mg twice daily, pantoprazole 40 mg twice daily, or rabeprazole 20 mg twice daily 3, 4
- Add H2-receptor antagonists, alginate, or antacid therapy sufficient to control heartburn/regurgitation 3
- Expected timeline: GI symptoms respond in 4-8 weeks; extraesophageal symptoms may require up to 3 months 1, 3, 2
For patients WITHOUT heartburn/regurgitation (isolated extraesophageal symptoms):
- Do NOT start empiric PPI therapy - PPIs alone without lifestyle modifications have not been shown effective and should not be used as isolated therapy 3
- Implement lifestyle modifications as primary intervention: weight loss if BMI >25, head of bed elevation, avoiding meals within 2-3 hours of bedtime, avoiding trigger foods 3
- Perform laryngoscopy first if laryngeal symptoms present 3
- Consider objective reflux testing (pH-metry) before empiric PPI therapy 3, 2
Step 2: Assess Treatment Response
After 8-12 weeks of appropriate therapy:
- If no improvement after 3 months, perform esophageal manometry and pH-metry rather than trying additional PPIs 1, 3, 2
- Do not continue empiric therapy beyond 3 months without response - proceed to objective testing instead 3
- Do not add nocturnal H2-receptor antagonists to twice-daily PPI therapy - there is no evidence of improved efficacy 3
Step 3: Alternative Treatments for Refractory Cases
Alternative treatment methods may serve a role in management of EER symptoms: 1
- Alginate-containing antacids 1
- External upper esophageal sphincter compression device 1
- Cognitive-behavioral therapy 1
- Neuromodulators (for laryngeal hypersensitivity) 3
Step 4: Surgical Consideration
Shared decision-making should be performed before referral for anti-reflux surgery for EER when the patient has clear, objectively defined evidence of GERD. 1
Critical caveat: Lack of response to PPI therapy predicts lack of response to anti-reflux surgery and should be incorporated into the decision process. 1
Pathophysiologic Mechanisms
Extraesophageal symptoms occur through two distinct pathways: 2
- Direct reflux pathway - refluxate directly contacts laryngopharyngeal tissues 2
- Reflex pathway - neurogenic signaling from esophageal acid exposure leads to inflammation and symptoms 1, 2
Controversy exists over whether fluid refluxate needs to be acidic or merely contain pepsin, or whether neurogenic signaling alone leads to inflammation and symptoms 1
Common Clinical Pitfalls
- Assuming PPI response confirms GERD diagnosis - variable responses to PPI therapy make this unreliable for extraesophageal symptoms 1
- Prescribing PPIs for isolated dysphonia without laryngoscopy - explicitly not recommended 3
- Continuing empiric therapy beyond 3 months without objective testing - this is low yield and delays appropriate diagnosis 3, 2
- Ignoring alternative diagnoses - many conditions associated with EER have higher incidence of acid reflux, making causation difficult to establish 1
Differential Diagnoses to Consider
For laryngeal/ENT symptoms: postnasal drip, laryngeal allergy, functional dysphonia, laryngeal papilloma, muscle tension dysphonia, vocal cord paralysis, vocal cord polyps, sinusitis, gastric inlet patch 1
For pulmonary symptoms: post-nasal drip, asthma, vocal cord dysfunction, medication reaction (ACE inhibitors), lung transplant rejection 1
For dental symptoms: poor dietary habits (acidic soft drinks, fruit juices), eating disorders with regurgitation (bulimia), xerostomia (Sjogren's), environmental exposure to acidic fumes 1